New Jersey Hospital Association
760 Alexander Road
P.O. Box 1
Princeton, NJ 08543-0001
October 5, 2026
Dear New Jersey Hospital Association (NJHA):
The
Justice Department and the DEA announced on 4/23/26 the issuance of an order (published 4/28) immediately
placing marijuana products regulated by a state medical marijuana license in
Schedule III of the Controlled Substances Act.
“The order
also recognizes that state medical cannabis programs are part of the medical
access landscape. State systems already regulate patient access, licensing,
dispensing, labeling, packaging, security, disposal, and recordkeeping. The
order relies on this existing state infrastructure to promote medical benefits
and avoid unnecessary disruption to patients and state systems. The order
recognizes medical cannabis patient registration as equivalent to a
prescription.”
At the
Capital Health Annual Public Meeting on August 25th, 2026, Dr. Joshua
Eisenberg said
that Capital Health is aware that the cannabis laws
have changed recently. A team is currently working to integrate cannabis use
for both in-patient and out-patient care so that it is done in a safe and
effective manner. He also said that we
can expect more information to come in the months ahead.
Surely we
cannot expect each individual healthcare facility in the state to study the
issue and develop its own policies. Treatment delayed is treatment denied and
only ensures that harm will come to patients who cannot access this provider
recommended/prescribed treatment. What action can the NJHA take to coordinate
the integration of medicinal cannabis into the Controlled Substances polices of
New Jersey’s healthcare facilities?
Thank you
for your consideration of this issue and your speedy reply.
Ken Wolski, RN, MPA
Chairman, Trenton Cannabis Advisory Committee
Executive
Director, Coalition for Medical Marijuana--New Jersey, Inc.
No comments:
Post a Comment